Searched for
GLAND PHARMA EARNINGS
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- F&O Talk: Weak market breadth to keep Nifty in sideways trend. Sudeep Shah's take on Amber, Tata Comm and 4 more stocksIndian markets ended higher on Friday, led by financial stocks, but analysts said Nifty remains trapped in a narrow range amid weak momentu...
- Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookGland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendShares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...
- Ceasefire calm or chaos? 50 stocks that brokerages expect to rally after Iran truceA two-week US-Iran ceasefire has sparked a relief rally in Indian equities, though its sustainability is questioned as oil prices rebound. ...
- Gland Pharma Q3 net profit rises 7% to Rs 205 croreGland Pharma on Monday reported 7% year-on-year (YoY) rise in net profit to Rs 205 crores in Q3FY25.
- Buy Gland Pharma, target price Rs 1,970: Motilal Oswal SecuritiesMotilal Oswal Securities recommends buying Gland Pharma stock. They predict a target price of Rs 1970. The brokerage expects Gland Pharma's...
- Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downsideGland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to 'Reduce' with ...
- Gland Pharma Q4 Results: Net profit more than doubles to Rs 192.4 croreThe company declared its first-ever post-listing dividend of Rs 20 per equity share for FY24.
- Gland Pharma shares climb over 6% post Q2 results. Should you buy or sell?Meanwhile, the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 320.5 crore, up from Rs 297 ...
- Gland Pharma surges 20% as biz momentum seen turningA better pricing environment in the US, impending product launches, and prospects of superior profitability are also seen boosting the earn...
- Gland Pharma shares zoom 20% as Q1 growth triggers upgradesGlobal brokerage firm Jefferies upgraded Gland Pharma's stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1...
- Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...
- A bitter pill! Gland Pharma records biggest fall since listing, hits 52-week lowAnother domestic brokerage firm Nirmal Bang Institutional Equities has cut its revenue and EBITDA estimates for the next three fiscals due ...
- Gland Pharma Q2 PAT declines 20% YoY to Rs 241 croreGland Pharma's consolidated revenue from operations stood at Rs 1,044 crore as against Rs 1,080 crore in the same quarter a year ago
- Gland Pharma plunges 12%, hits 52-week low on flop show in Q1The company's profit fell by 36.7 per cent year-on-year (YoY) to Rs 221.9 crore in the said quarter from Rs 350.65 crore in the same period...
- Gland Pharma IPO: Issue date, price band & other key detailsThe drugmarker will likely announce the name of anchor investors by the end of Friday.
Load More
